Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chal E. Tomlinson
Observed names:
Chalmer E. Tomlinson,
Chalmer Tomlinson
Institution:
Johnson & Johnson (United States)
Observed institutions:
University of North Carolina at Chapel Hill,
Johnson & Johnson (United States),
Janssen Research & Development (United States)
ORCID:
0000-0003-4322-930X
Observed ORCID:
0000-0003-4322-930X
OpenAlex ID:
A5085633273
Heart-brain connections: Phenotypic and genetic insights from magnetic resonance images
2023
·
Bingxin Zhao
, Tengfei Li
, et al.
·
Science
·
240
PDF
Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab
2024
·
Ajai Chari
, Amrita Krishnan
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
51
Associations of physical function and body mass index with functional brain networks in community-dwelling older adults
2023
·
Paul J. Laurienti
, Michael E. Miller
, et al.
·
Neurobiology of Aging
·
19
A regression framework for brain network distance metrics
2021
·
Chal E. Tomlinson
, Paul J. Laurienti
, et al.
·
Network Neuroscience
·
15
The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations
2020
·
Anastasia Ivanova
, Elliot Israel
, et al.
·
Journal of Biopharmaceutical Statistics
·
15
PDF
Talquetamab improves patient‐reported symptoms and health‐related quality of life in relapsed or refractory multiple myeloma: Results from the phase 1/2 MonumenTAL‐1 study
2025
·
Carolina Schinke
, Cyrille Touzeau
, et al.
·
Cancer
·
12
PDF
Efficacy and safety from the phase 1/2 MonumenTAL-1 study of talquetamab, a GPRC5D×CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma: Analyses at an extended median follow-up.
2025
·
Leo Rasche
, Carolina D. Schinke
, et al.
·
Journal of Clinical Oncology
·
8
Genetic influences on the shape of brain ventricular and subcortical structures
2022
·
Bingxin Zhao
, Tengfei Li
, et al.
·
medRxiv
·
4
PDF
Association of physical function with connectivity in the sensorimotor and dorsal attention networks: why examining specific components of physical function matters
2024
·
Madeline C. Boyd
, Jonathan H. Burdette
, et al.
·
GeroScience
·
3
Heart-brain connections: phenotypic and genetic insights from 40,000 cardiac and brain magnetic resonance images
2021
·
Bingxin Zhao
, Tengfei Li
, et al.
·
medRxiv
·
3
PDF
A Regression Framework for Brain Network Distance Metrics
2021
·
Chal E. Tomlinson
, Paul J. Laurienti
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
3
PDF
Effects of anesthesia exposure on postnatal maturation of white matter in rhesus monkeys
2023
·
Chalmer Tomlinson
, Roza Vlasova
, et al.
·
Developmental Psychobiology
·
2
PDF
Moderation between resting-state connectivity and brain amyloid levels on speed of cognitive and physical function in older adults: Evidence for network-based cognitive reserve
2025
·
Paul J. Laurienti
, Stephen B. Kritchevsky
, et al.
·
Aperture Neuro
·
1
PDF
3M_BANTOR: A regression framework for multitask and multisession brain network distance metrics
2022
·
Chal E. Tomlinson
, Paul J. Laurienti
, et al.
·
Network Neuroscience
·
1
PDF
Associations of Functional Brain Networks with Physical Function and Body Mass Index in Community-Dwelling Older Adults
2022
·
Paul Laurienti
, Michael E. Miller
, et al.
·
SSRN Electronic Journal
·
1
Talquetamab in patients with relapsed/refractory multiple myeloma: 3-year follow-up of the phase 1/2 MonumenTAL-1 study
2026
·
Leo Rasche
, Carolina Schinke
, et al.
·
Blood
A plain language summary describing how talquetamab affects the way people with multiple myeloma feel and function in the MonumenTAL-1 study
2026
·
Carolina Schinke
, Cyrille Touzeau
, et al.
·
Future Oncology
POSTER: MM-215 Efficacy And Safety from the Phase 1/2 Monumental-1 Study of Talquetamab, a GPRC5D × CD3 Bispecific Antibody, in Patients With Relapsed/Refractory Multiple Myeloma: Analyses at an Extended Median Follow-Up
2025
·
Leo Rasche
, Carolina Schinke
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
MM-215: Efficacy And Safety from the Phase 1/2 Monumental-1 Study of Talquetamab, a GPRC5D × CD3 Bispecific Antibody, in Patients With Relapsed/Refractory Multiple Myeloma: Analyses at an Extended Median Follow-Up
2025
·
Leo Rasche
, Carolina Schinke
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
T60. The Longitudinal Study of Anesthesia Effects on White Matter Development
2019
·
Chalmer Tomlinson
, Jeffrey Young
, et al.
·
Biological Psychiatry
Show more works
View as search
Works count:
20
Citation count:
378
H-index:
7
I10-index:
6
Year
Topic
Type